Open AccessAdvancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals
Author(s) -
Yuping Xu
Publication year - 2016
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v8.i2.165
Subject(s) - medicine , pancreatic cancer , modalities , cancer , molecular imaging , disease , treatment modality , medical physics , pathology , social science , microbiology and biotechnology , sociology , in vivo , biology
Pancreatic cancer (PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition, radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.